Results 241 to 250 of about 203,196 (295)

Successful fatherhood of males with tyrosine kinase inhibitor-resistant chronic myeloid leukemia taking olverembatinib. [PDF]

Ann Hematol
Yu L, Jiang Q.
europepmc   +1 more source

Prophylactic Donor Lymphocyte Infusions in Pediatric Patients With High‐Risk Hematological Malignancies

European Journal of Haematology, EarlyView.
ABSTRACT Introduction Allogeneic stem cell transplantation (allo‐SCT) and donor lymphocyte infusions (DLI) can elicit a graft‐versus‐leukemia (GvL) effect in pediatric patients with hematological malignancies. We report our single‐center experience with prophylactic DLI in high‐risk pediatric patients with leukemia or lymphoma, focusing on feasibility,
Denise Epple, Katja Gall, Luisa Paschke, Hans‐Jochem Kolb, Angela Wawer, Hans Knabe, Irene von Luettichau, Julia Hauer, Uwe Thiel   +8 more
wiley   +1 more source

Pediatric chronic myeloid leukemia: A decade of clinical experience at the NBK specialized hospital for children. [PDF]

Leuk Res Rep
Bourusly M, Obaid MA, Farag N, Bourhama M, Alsharidah S, Almatar E.   +5 more
europepmc   +1 more source

Potential differences between real-life and randomized controlled trial populations in chronic myeloid leukemia. [PDF]

Ann Hematol
Horňák T, Žáčková D, Mayer J.
europepmc   +1 more source

Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy. [PDF]

BMC Cancer
Arif K, Yousaf M, Khan D.
europepmc   +1 more source

Chronic Myeloid Leukemia in a Young Adult. [PDF]

Cureus
Patel K, Syed J, Jagadish A, Vedantam V, Daugherty D.   +4 more
europepmc   +1 more source

Giant cellulitis‐like Sweet's syndrome induced by gilteritinib

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Juan de Luque‐Fernández, Irene Rivera‐Ruiz, Irene Suárez‐Vergne, Inmaculada Sánchez‐Ramírez, Manuel Galán‐Gutiérrez, Antonio José Vélez García‐Nieto   +5 more
wiley   +1 more source

Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia. [PDF]

Leukemia
Curik N, Laznicka A, Krizkova J, Suchankova P, Vavrova A, Polivkova V, Pokorna E, Semerak P, Burda P, Kuzilkova D, Kalina T, Hochhaus A, Machova Polakova K.   +12 more
europepmc   +1 more source

Identification of a Novel miR-122-5p/CDC25A Axis and Potential Therapeutic Targets for Chronic Myeloid Leukemia. [PDF]

Int J Mol Sci
Ozer Yaman S, Petrović N, Yaman S, Akidan O, Cimbek A, Baycelebi G, Srdić-Rajić T, Šami A, Misir S.   +8 more
europepmc   +1 more source